We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.
- Authors
Silverman, Lewis R; McKenzie, David R; Peterson, Bercedis L; Holland, James F; Backstrom, Jay T; Beach, C L; Larson, Richard A; Cancer and Leukemia Group B
- Abstract
Within the last two decades, a new understanding of the biology of myelodysplastic syndrome (MDS) has developed. With this understanding, new classification systems, such as the WHO diagnostic criteria, and the International Prognostic Scoring System and response criteria guidelines reported by the International Working Group (IWG) have been developed. We report the combined results of three previously reported clinical trials (n = 309) with azacitidine using the WHO classification system for MDS and acute myeloid leukemia (AML) and IWG criteria for response.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 24, p3895
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.05.4346